Pancreatic Cancer Research

ResearcherUniversity of IowaNo recent work listed

Xuefeng Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5030-2766; OpenAlex author ID A5100402643. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper

Papers 7

  1. Splenic-vasculature involvement is associated with poor prognosis in resected distal pancreatic cancer. Co-author DOI 10.1093/gastro/goaa084↗
  2. Validation of American Joint Committee on Cancer 8th edition of TNM staging in resected distal pancreatic cancer. Co-author DOI 10.4292/wjgpt.v11.i2.25↗
  3. Potential functional variants in SMC2 and TP53 in the AURORA pathway genes and risk of pancreatic cancer. Co-author DOI 10.1093/carcin/bgz029↗
  4. Three novel genetic variants in NRF2 signaling pathway genes are associated with pancreatic cancer risk. Co-author DOI 10.1111/cas.14017↗
  5. Pancreatic ductal adenocarcinoma with autoimmune pancreatitis-like histologic and immunohistochemical features. Co-author DOI 10.1016/j.humpath.2013.08.027↗
  6. RABL6A Promotes Oxaliplatin Resistance in Tumor Cells and Is a New Marker of Survival for Resected Pancreatic Ductal Adenocarcinoma Patients. Co-author DOI 10.1177/1947601913501074↗
  7. The ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ductal adenocarcinoma metastasis. Co-author DOI 10.1158/1541-7786.mcr-10-0475↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiuli Liu · 3 shared papers, 2014–2021 · strength 0.24
  2. James L. Abbruzzese · 2 shared papers, 2019 · strength 0.19
  3. Bensong Duan · 2 shared papers, 2019 · strength 0.19
  4. Teena Dhir · 2 shared papers, 2020–2021 · strength 0.19
  5. Christopher William Schultz · 2 shared papers, 2020–2021 · strength 0.19
  6. Richard Zheng · 2 shared papers, 2020–2021 · strength 0.19
  7. Hao Xie · 2 shared papers, 2020–2021 · strength 0.19
  8. Bing Ren · 2 shared papers, 2020–2021 · strength 0.19
  9. Feng Yin · 2 shared papers, 2020–2021 · strength 0.19
  10. Wei Jiang · 2 shared papers, 2020–2021 · strength 0.19
  11. Yun Feng · 1 shared paper, 2019 · strength 0.10
  12. Qingyi Wei · 1 shared paper, 2019 · strength 0.10
  13. Wenjun Yang · 1 shared paper, 2019 · strength 0.09
  14. Qingyi Wei Wei · 1 shared paper, 2019 · strength 0.09
  15. Xinyuan Xu · 1 shared paper, 2019 · strength 0.09
  16. Dawn E Quelle · 2 shared papers, 2011–2013 · strength 0.06
  17. Viviane Palhares Muniz · 2 shared papers, 2011–2013 · strength 0.06
  18. Shu‐Yuan Xiao · 1 shared paper, 2014 · strength 0.05
  19. James J. Mezhir · 1 shared paper, 2013 · strength 0.03
  20. Bradley D. McDowell · 1 shared paper, 2013 · strength 0.03
  21. B. J. Smith · 1 shared paper, 2013 · strength 0.03
  22. Steven R. Grossman · 1 shared paper, 2011 · strength 0.02
  23. Joseph J. Cullen · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.